Innovax^®-ILT-IBD concentrate and solvent for suspension for injection for chickens

Innovax-ILT-IBD provides effective 3 in 1 protection against Marek's Disease, Infectious Laryngotracheitis and Infectious Bursal Disease. Administered at the hatchery, Innovax-ILT-IBD removes the need for multiple live vaccinations on farm, saving valuable time and labour.

Presentation

Off red to red cell concentrate and clear red solution as solvent for suspension for injection.

Active ingredients

Each dose of reconstituted vaccine (0.2 ml for subcutaneous use or 0.05 ml for in ovo use) contains:

Active substance: Cell-associated live recombinant turkey herpesvirus (strain HVT/IBD/ILT), expressing the VP2 protein of infectious bursal disease virus and the glycoproteins gD and gI of infectious laryngotracheitis virus: 10^3.2 – 10^4.6 PFU*.

*PFU – plaque forming units.

Target species

Chickens and embryonated chicken eggs.

Indications for use

For active immunisation of one-day-old chicks or 18-19 day-old embryonated eggs:

• to reduce mortality, clinical signs and lesions caused by avian infectious laryngotracheitis (ILT) virus and Marek’s disease (MD) virus.
• to prevent mortality and to reduce clinical signs and lesions caused by infectious bursal disease (IBD) virus.

Onset of immunity: IBD: 3 weeks of age, ILT: 4 weeks of age, MD: 5 days of age.

Duration of immunity: IBD: 100 weeks, ILT: 100 weeks, MD: entire risk period.

Withdrawal periods

Poultry - meat 0 days

Packaging

Concentrate:  Type I glass ampoule of 2 ml containing 2,000 or 4,000 doses. Ampoules are stored on a cane and attached to the cane is a coloured clip displaying the dose (2,000 doses: salmon-pink coloured clip, and 4,000 doses: yellow coloured clip).

Solvent:

• One 400 ml multilayer plastic bag.
• One 800 ml multilayer plastic bag.

Not all pack sizes may be marketed.

Legal category

POM-V

Date of preparation: April 2024